Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the Europe

A le Cesne, I Judson, D Crowther, S Rodenhuis, HJ Keizer, Q van Hoesel, JY Blay, J Frisch, M Glabbeke, C Hermans, AT van Oosterom, T Tursz, Jaap Verweij

Research output: Contribution to journalArticleAcademicpeer-review

229 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2676-2684
Number of pages9
JournalJournal of Clinical Oncology
Issue number14
Publication statusPublished - 2000

Research programs

  • EMC MM-03-86-08

Cite this